LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026
Rhea-AI Summary
LifeVantage (Nasdaq:LFVN) will release third quarter fiscal 2026 results for the period ended March 31, 2026, after market close on Wednesday, May 6, 2026. A conference call for investors is scheduled for 2:30 p.m. MT / 4:30 p.m. ET that day.
Telephone dial-in numbers, replay details with confirmation code, and a simultaneous live webcast (archived ~30 days) are provided for investor access.
Positive
- None.
Negative
- None.
News Market Reaction – LFVN
In the Apr 23 session, LFVN gained 1.22%, reflecting a mild positive market reaction. Argus tracked a peak move of +6.3% during that session. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 21 | Earnings date notice | Neutral | +4.7% | Set release and call timing for fiscal 2026 Q2 results. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Limited same-tag history: the last earnings-date announcement saw a 4.74% positive next-day move.
This announcement sets the timing for LifeVantage’s third quarter fiscal 2026 results, matching the structure of the prior earnings date notice on Jan 21, 2026, which previewed Q2 results. That earlier scheduling release was followed by a 4.74% gain over the next 24 hours. With only one comparable event, the pattern so far shows neutral procedural news coinciding with a modestly positive market reaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, April 22, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2026, after the stock market closes on Wednesday, May 6, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, May 20, 2026, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13759699, or (412) 317-6671 from international locations, and entering confirmation code 13759699.
There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1758157&tp_key=76e0807216. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and the comprehensive gut activator, P84, and activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
